GLP-1s can open the door to better health, but true transformation happens when medicine meets education, nourishment and self-care
If you want help deciding whether this medication is a fit, take the free assessment quiz
The FDA has accepted Eli Lilly's regulatory submission for orforglipron in obesity, with a target action date of April 10, 2026, under the Commissioner's National Priority Review Voucher program
Factors Affecting GLP-1 Treatment Costs in the UK Several factors influence the overall cost of GLP-1 treatment, extending beyond the medication price alone
Ao estimular os receptores de GLP-1, GIP e glucagon, o medicamento promove uma sensao de saciedade prolongada e aumenta o gasto energtico, contribuindo para a perda de peso
GLP-1s may be better than other diabetes drugs at helping with liver fat, according to a study published in 2023